Panagiotis Kottaridis

Author

Also Known As

Kottaridis, P, Kottaridis, PD, P D Kottaridis, P Kottaridis, P. Kottaridis, P.D. Kottaridis, Panagiotis D Kottaridis, Panagiotis D. Kottaridis, Panagiotis Kottaridis, Panos Kottaridis

116

Publications

6.3K

Citations

H-Index

Concepts

All Affiliations

University College London The Royal Free Hospital University College Hospital University of Birmingham The Christie NHS Foundation Trust

About

Panagiotis Kottaridis is an author at University College London specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	446
2	Blood Transplantation	5	5	157
3	Health Sciences	4	4	241
4	Cell Biology	4	4	195
5	Cellular Therapies	3	3	97

Panagiotis Kottaridis

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials Panagiotis Kottaridis, Rosemary E. Gale, Marion E. Frew, Blood	2001	1.5K
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation Panagiotis Kottaridis, Donald Milligan, Rajesh Chopra, Blood	2000	502
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution Suparno Chakrabarti, Stephen Mackinnon, Raj Chopra, Blood	2002	359
Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen Ronjon Chakraverty, Karl S. Peggs, Rajesh Chopra, Blood	2002	344
Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors Panagiotis Kottaridis, Rosemary E. Gale, Stephen E. Langabeer, Blood	2002	304
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders Josè Antonio Pérez-Simón, Panagiotis Kottaridis, Rodrigo Martino, Blood	2002	243
No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials Rosemary E. Gale, Robert K. Hills, Panagiotis Kottaridis, Blood	2005	217
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia Rosemary E. Gale, Robert K. Hills, Arnold Pizzey, Blood	2005	199
The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation Andrea Knight, J. Alejandro Madrigal, Sarah Grace, Blood	2010	185
Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data Rafael F. Duarte, Bronwen E. Shaw, Panagiotis Kottaridis, Bone Marrow Transplantation Hematological MalignancyOncologyMedicineStem Cell MobilizationImmunology	2010	132

Page 1